A Phase I/II Study to Evaluate a SARS-CoV-2 mRNA Vaccine in Healthy Adults

NCT05903118 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
480
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Argorna Pharmaceuticals Co., LTD